UK-based pharmaceutical conglomerate GlaxoSmithKline (GSK) and UK-based automotive company the McLaren Group signed a strategic agreement yesterday, set to run initially until 2016. GSK is looking to harness McLaren’s expertise in analytics and data modelling, which it will chiefly use in its nutritionals unit, as well as in manufacturing, consumer healthcare and research & development.…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
